NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX)
Post# of 231
(Total Views: 208)
Posted On: 06/05/2019 3:50:10 PM
NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Developing Gene Therapy-based Approach to Treat Non-small Cell Lung Cancer
Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is developing Oncoprex immunogene therapy as an innovative, gene therapy-based approach for the treatment of non-small cell lung cancer (“NSCLC”). An article further discussing the company reads, “NSCLC is the most common type of lung cancer. It accounts for approximately 85% of all lung-cancer cases, and despite the development of innovative treatment strategies, the survival rate for lung cancer patients has not improved significantly over the past 25 years (http://nnw.fm/0YVIu) . . . . Breakthrough technologies and therapeutic approaches like those developed by Genprex could take cancer treatment solutions to a new level of effectiveness. Gene therapy could be the one innovative development that will contribute to curing what’s currently incurable, and companies like Genprex are spearheading these efforts.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Clinical-stage, gene-therapy company Genprex (NASDAQ: GNPX) is developing Oncoprex immunogene therapy as an innovative, gene therapy-based approach for the treatment of non-small cell lung cancer (“NSCLC”). An article further discussing the company reads, “NSCLC is the most common type of lung cancer. It accounts for approximately 85% of all lung-cancer cases, and despite the development of innovative treatment strategies, the survival rate for lung cancer patients has not improved significantly over the past 25 years (http://nnw.fm/0YVIu) . . . . Breakthrough technologies and therapeutic approaches like those developed by Genprex could take cancer treatment solutions to a new level of effectiveness. Gene therapy could be the one innovative development that will contribute to curing what’s currently incurable, and companies like Genprex are spearheading these efforts.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Genprex Inc. (GNPX) Stock Research Links
Scroll down for more posts ▼